Search Within

GME, Medicine

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (146)
  2. Journal Article (143)
  3. Research Letter (8)
  4. Review (4)
  5. Editorial (3)
Groups
  1. Graduate Medical Education (304)
  2. Human Oncology and Pathogenesis Program (304)
  3. GSK Faculty (300)
  4. Department of Medicine (290)
  5. Hematology-Oncology Fellows (247)
  6. Solid Tumor Oncology Division (202)

More Groups

People
  1. Michael Berger (67)
  2. Nikolaus Schultz (53)
  3. Marc Ladanyi (48)
  4. Marcel Van Den Brink (40)
  5. David Solit (35)
  6. Santosha Vardhana (34)

More People

Years
  1. 2025 (21)
  2. 2024 (75)
  3. 2023 (81)
  4. 2022 (53)
  5. 2021 (17)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (68)
  2. Blood (31)
  3. Clinical Cancer Research (20)
  4. Cancer Research (17)
  5. Annals of Oncology (12)
  6. JCO Precision Oncology (10)

More Publications

Publishers
  1. American Society of Clinical Oncology (78)
  2. American Association for Cancer Research (45)
  3. American Society of Hematology (35)
  4. Elsevier Inc. (29)
  5. Nature Publishing Group (24)
  6. Oxford University Press (24)

More Publishers

Results (304)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Shareable artificial intelligence to extract cancer outcomes from electronic health records
    Meeting Abstract

    Kehl, K. L.; Jee, J.; Pichotta, K.; Trukhanov, P.; Fong, C.; Waters, M.; Nichols, C.; Cerami, E.; Schrag, D.; Schultz, N.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Real world outcomes of sequential ADC therapy in metastatic breast cancer: Patients treated with sacituzumab govitecan and trastuzumab deruxtecan
    Meeting Abstract

    Mai, N.; Klar, M.; Ferraro, E.; Bromberg, M.; Chen, Y.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Walsh, E. M.; Drago, J. Z.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer (PDAC): Long-term outcomes and correlative insights
    Meeting Abstract

    Keane, F.; Tuli, R.; O'Connor, C. A.; Schwartz, C.; Park, W.; Varghese, A. M.; Perry, M.; Singhal, A.; Vardhana, S.; Hendifar, A. E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Effect of CDC7 inhibition and MYC degradation on neuroendocrine transformation in the lung and prostate cancer
    Meeting Abstract

    Quintanal-Villalonga, A.; Kawasaki, K.; Redin, E.; Rakhade, S.; Durani, V.; Sabet, A.; Karthaus, W.; Zaidi, S.; Zhan, Y. A.; Manoj, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Personalized circulating tumor DNA for minimal residual disease and dynamic assessment in patients undergoing neoadjuvant chemotherapy for breast cancer: Preliminary analysis from MSK-LINC
    Meeting Abstract

    Kim, H. K.; An, J. A. R.; Smith, C. G.; Kim, J.; Cabel, L.; Moiso, E.; Ferraro, E.; Safonov, A.; Nelson, K.; Szuhany, K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Overall survival analysis of first line CDK4/6 inhibitors in a large real-world cohort of patients with hormone receptor-positive (HR+)/HER2-negative metastatic breast cancer
    Meeting Abstract

    Ferraro, E.; Moiso, E.; Safonov, A.; Cabel, L.; Loudon, L.; Dang, C. T.; Shen, S.; Jhaveri, K. L.; Robson, M. E.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 study of amivantamab plus lazertinib in patients with EGFR-mutant lung cancer and active central nervous system disease
    Meeting Abstract

    Yu, H. A.; Chen, M. F.; Hui, A. B.; Choudhury, N. J.; Lee, J. J. K.; Zheng, J.; Ahn, L. S. H.; Pupo, A.; Nesselbush, M.; Jabara, I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Immune checkpoint inhibition for the treatment of metastatic breast cancer with high tumor mutational burden: Real world clinical and genomic correlates of response
    Meeting Abstract

    Mai, N.; Safonov, A.; Marra, A.; Chen, Y.; Chandarlapaty, S.; Razavi, P.; Plitas, G.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Predicting CDK4/6 inhibitors outcomes in pts with HR+/HER2-metastatic breast cancer: A machine learning approach
    Meeting Abstract

    Moiso, E.; Ferraro, E.; Cabel, L.; Safonov, A.; Ahmed, M.; An, J. A. R.; Jhaveri, K. L.; Norton, L.; Robson, M. E.; Modi, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Genomic biomarkers of CNS-specific outcomes in patients with breast cancer brain metastases
    Meeting Abstract

    Khatri, I. S.; Eichholz, J.; Boe, L. A.; Safonov, A.; Smith, D. R.; Ferraro, E.; Shen, J.; Imber, B. S.; Yu, Y.; Yamada, Y.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save